Should Pre-Transplant Hemoglobin A1c Be Used to Predict Post-Transplant Compliance in End-Stage Renal Disease Patients Undergoing Kidney Transplantation?
CONCLUSIONS In diabetic ESRD patients selected for renal transplantation, elevated pre-transplant HbA1c levels, defined as HbA1c >7.7%, are not predictive of post-transplant medication compliance. We advocate that this group of patients should not be denied transplant solely on their elevated pre-transplant HbA1c.
PMID: 32587234 [PubMed - in process]
Source: Annals of Transplantation - Category: Transplant Surgery Authors: Terranella SL, Poirier J, Chan EY, Hertl M, Olaitan OK Tags: Ann Transplant Source Type: research
More News: Diabetes | Endocrinology | Kidney Transplant | Kidney Transplantation | Statistics | Study | Transplant Surgery | Transplants | Urology & Nephrology